Aflac Incorporated (NYSE:AFL) Shares Sold by LSV Asset Management

Key Points

• LSV Asset Management reduced its stake in Aflac by 33.2%, selling 691,377 shares in the first quarter of 2023, leaving them with approximately 1.39 million shares valued at $154.59 million.
• Aflac reported a net margin of 21.27% and a year-over-year revenue decrease of 37.5%, with earnings per share of $1.66 for the latest quarter, missing estimates.
• Institutional investors hold around 67.44% of Aflac's stock, with several firms adjusting their price targets for the stock, currently averaging $108.15 according to analysts.

LSV Asset Management lowered its position in Aflac Incorporated (NYSE:AFL - Free Report) by 33.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,390,323 shares of the financial services provider's stock after selling 691,377 shares during the quarter. LSV Asset Management owned approximately 0.25% of Aflac worth $154,590,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in AFL. Brighton Jones LLC grew its position in Aflac by 64.4% during the 4th quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider's stock worth $1,507,000 after acquiring an additional 5,708 shares during the last quarter. OneAscent Financial Services LLC lifted its stake in shares of Aflac by 16.1% in the 4th quarter. OneAscent Financial Services LLC now owns 2,349 shares of the financial services provider's stock valued at $243,000 after purchasing an additional 326 shares during the period. World Investment Advisors lifted its stake in shares of Aflac by 28.4% in the 4th quarter. World Investment Advisors now owns 6,817 shares of the financial services provider's stock valued at $705,000 after purchasing an additional 1,507 shares during the period. Motley Fool Asset Management LLC lifted its stake in shares of Aflac by 12.9% in the 4th quarter. Motley Fool Asset Management LLC now owns 25,451 shares of the financial services provider's stock valued at $2,633,000 after purchasing an additional 2,910 shares during the period. Finally, Yoffe Investment Management LLC bought a new stake in shares of Aflac in the 4th quarter valued at $465,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the transaction, the director owned 26,096 shares in the company, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director directly owned 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 40,750 shares of company stock worth $4,304,295. Insiders own 0.80% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on AFL shares. Morgan Stanley increased their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Wells Fargo & Company boosted their target price on shares of Aflac from $103.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 10th. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Keefe, Bruyette & Woods raised their price target on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Finally, Barclays set a $98.00 price objective on Aflac and gave the company an "underweight" rating in a research note on Monday, July 7th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $108.15.

Aflac Stock Down 1.3%

AFL traded down $1.26 during midday trading on Friday, reaching $98.10. The company's stock had a trading volume of 2,768,314 shares, compared to its average volume of 2,180,205. The stock's 50-day moving average is $102.58 and its 200-day moving average is $105.06. The firm has a market capitalization of $53.04 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 3.03 and a beta of 0.83. Aflac Incorporated has a 1 year low of $95.97 and a 1 year high of $115.50. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm's revenue for the quarter was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.66 earnings per share. As a group, research analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.